Cargando…
Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives
A novel infectious disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was detected in December 2019 and declared as a global pandemic by the World Health. Approximately 15% of patients with COVID-19 progress to severe pneumonia and eventually develop acute re...
Autores principales: | Chiappalupi, Sara, Salvadori, Laura, Vukasinovic, Aleksandra, Donato, Rosario, Sorci, Guglielmo, Riuzzi, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900755/ https://www.ncbi.nlm.nih.gov/pubmed/33636175 http://dx.doi.org/10.1016/j.lfs.2021.119251 |
Ejemplares similares
-
Hyperactivated RAGE in Comorbidities as a Risk Factor for Severe COVID-19—The Role of RAGE-RAS Crosstalk
por: Chiappalupi, Sara, et al.
Publicado: (2021) -
RAGE in the pathophysiology of skeletal muscle
por: Riuzzi, Francesca, et al.
Publicado: (2018) -
Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia
por: Chiappalupi, Sara, et al.
Publicado: (2020) -
Do porcine Sertoli cells represent an opportunity for Duchenne muscular dystrophy?
por: Chiappalupi, Sara, et al.
Publicado: (2019) -
S100B Engages RAGE or bFGF/FGFR1 in Myoblasts Depending on Its Own Concentration and Myoblast Density. Implications for Muscle Regeneration
por: Riuzzi, Francesca, et al.
Publicado: (2012)